Preparation method of adenosine and use thereof
By using TBD catalyst and atmospheric ammonization reaction in adenosine preparation, the unfriendly problem of Vilsmeier reagent is solved, the yield and purity of adenosine are improved, and the environmentally friendly and efficient preparation process is achieved.
Patent Information
- Application Number
- CN202310416368.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-02-13
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2043-02-13
AI Technical Summary
The existing adenosine preparation method uses unfriendly Vilsmeier reagents, and produces a large number of impurities under high pressure and high temperature conditions, affecting the yield and purity of the product.
Using 1,5,7-triazide bicyclic (4.4.0)dec-5-ene (TBD) as a catalyst, the amine transesterification reaction between 6-chloropurine and tetraacetyl ribose was carried out, and then the presence of the base under normal pressure was performed. The ammonization reaction is carried out under the slightest ammonia reaction, avoiding the use of Vilsmeier reagent and high temperature and high pressure conditions to reduce the generation of impurities.
The reaction yield and purity of adenosine are improved, and the environmentally friendly preparation process is achieved. The purity of the product reaches more than 99.9%, which is suitable for large-scale industrial production.
Smart Images

Figure BDA0004189163900000011 
Figure BDA0004189163900000021 
Figure BDA0004189163900000031
Abstract
Description
[0001] This application is a divisional application of the Chinese invention patent application with the application date of February 13, 2023, application number 2023101872764, and invention name “Method for preparing adenosine and its use”. Technical Field
[0002] The invention belongs to the field of drug synthesis, and in particular relates to a preparation method of adenosine and a use thereof. Background Art
[0003] Adenosine is a naturally occurring, endogenous purine nucleoside found throughout human cells. It is a degradation product of adenosine triphosphate (ATP). Adenosine is well known for its vasodilatory effect. In addition to its wide range of cardiac effects and rapid and significant coronary dilation, it also has cardioprotective effects such as triggering or mediating ischemic preconditioning and reducing reperfusion injury. In the United States, adenosine is an FDA-approved first-line drug for converting paroxysmal supraventricular tachycardia (PSVT). It is also one of the two FDA-approved drugs for cardiac drug stress testing and has become a routine drug for emergency treatment of tachyarrhythmias and drug stress testing. In addition, adenosine is also an important pharmaceutical raw material. Adenosine can be used to make many drugs such as ATP, cyclic adenosine monophosphate, and adenosine arabinoside.
[0004] Chinese patent applications CN1408720A, CN100460416C, CN111808157B and other patents all disclose methods for preparing adenosine. However, the adenosine preparation process of these three patents uses Vilsmeier reagent for chlorination. As is well known, Vilsmeier reagent is not environmentally friendly and corrosive to equipment. In addition, the aminolysis process involved needs to be carried out in high-pressure equipment, which has high requirements on the equipment and poses safety risks in the production process.
[0005] In addition, in the adenosine preparation methods of Chinese patent applications CN1408720A and CN100460416C, the aminolysis process is carried out in a solution of ammonia methanol or other fatty alcohols in which ammonia is dissolved, which will produce a large amount of impurities under high temperature and high pressure conditions, greatly affecting the yield of the product.
[0006] For example, in the adenosine preparation method of CN100460416C, the intermediate compound triacetylinosine chloride can produce impurity I in a methanol-ammonia solution under high temperature and high pressure conditions through the following reaction formula:
[0007]
[0008] It is estimated that the content of impurity I in the reaction solution is 10-15%.
[0009] For another example, in the adenosine preparation method of CN1408720A, methanol and ammonia may produce some methylamine under high temperature and high pressure conditions, and the intermediate compound (IV) easily produces 6-chloronucleoside in a methanol-ammonia solution. The methylamine produced above can react with 6-chloronucleoside to produce impurity II. The reaction formula of the process is as follows:
[0010]
[0011] It is estimated that the content of impurity II in the reaction solution is 5-10%.
[0012] Therefore, there is an urgent need for an environmentally friendly adenosine preparation process with fewer impurities and higher yield.
[0013] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention and should not be regarded as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art. Summary of the invention
[0014] Purpose of the Invention
[0015] In view of the above-mentioned problems existing in the prior art, the object of the present invention is to provide an environmentally friendly method for preparing adenosine and its use which has greatly improved reaction yield and product purity.
[0016] Solution
[0017] To achieve the purpose of the present invention, the present invention provides the following technical solutions:
[0018] A method for preparing adenosine, the method comprising the following steps:
[0019] (a) in the presence of a catalyst, 1,5,7-triazidobicyclo(4.4.0)dec-5-ene (TBD for short), 6-chloropurine is subjected to an amine ester exchange reaction with tetraacetylribose to obtain chlorotriacetylinosine;
[0020] (b) in the presence of a base, under normal pressure and heating conditions, subjecting triacetylinosine chloride to an aminating reaction with an aminating agent to obtain adenosine;
[0021] The reaction formula of the preparation method is as follows:
[0022]
[0023] For the above preparation method:
[0024] Preferably, in step (a), the molar ratio of 6-chloropurine to tetraacetylribose is 1:(1-2), preferably 1:(1.2-1.4).
[0025] Preferably, in step (a), the molar ratio of 6-chloropurine to the catalyst 1,5,7-triazidebicyclo(4.4.0)dec-5-ene is 1:(0.01-0.2), preferably 1:0.05.
[0026] Preferably, in step (a), the amine transesterification reaction is carried out in a solvent, and the solvent is tetrahydrofuran and / or 1,4-dioxane.
[0027] Preferably, in step (a), the amine transesterification reaction is carried out at 40-60°C, preferably 50-60°C.
[0028] Preferably, in step (b), the base is selected from one or more of triethylamine, diethylamine and diisopropylethylamine.
[0029] Preferably, in step (b), the molar ratio of triacetylinosine chloride to the base is 1:(1-2), preferably 1:(1.2-1.4).
[0030] Preferably, in step (b), the aminating agent is selected from: one or more of ammonia, ammonium chloride, ammonium carbonate and ammonium acetate, preferably selected from: one or more of ammonia water, ammonium chloride aqueous solution, ammonium carbonate aqueous solution and ammonium acetate aqueous solution, more preferably ammonia water, ammonium chloride aqueous solution, ammonium carbonate aqueous solution or ammonium acetate aqueous solution.
[0031] Preferably, in step (b), the normal pressure is one atmosphere, i.e., about 0.1 MPa; the heating condition refers to heating to 40-60°C, preferably 50-60°C, that is, the amination reaction is carried out at 40-60°C, preferably 50-60°C.
[0032] Preferably, step (b) further comprises the step of cooling and crystallizing the product for purification after the amination reaction is completed; further preferably, the purification solvent is water.
[0033] In addition, the present invention also provides the use of the above-mentioned method for preparing adenosine in preparing adenosine.
[0034] Beneficial Effects
[0035] 1) The method for preparing adenosine of the present invention does not use Vilsmeier reagent, so the preparation method is more environmentally friendly.
[0036] 2) According to the method for preparing adenosine of the present invention, the first step of the amine transesterification reaction uses a specific catalyst TBD, so that the reaction yield and purity are greatly improved; the second step of the amination reaction introduces alkaline reagents such as triethylamine, diethylamine, and diisopropylethylamine, so that the reaction can be carried out under normal pressure. In addition, the amination reaction does not use ammonia solutions of fatty alcohols including ammonia methanol as ammonia reagents, and is carried out at normal pressure and below 100° C. Therefore, it is highly safe and does not produce a large amount of impurities, so that the purity of the product is greatly improved.
[0037] 3) The method for preparing adenosine of the present invention further comprises a step of cooling and crystallizing for purification, and the purity of the obtained adenosine raw material is further improved.
[0038] In summary, the adenosine preparation method of the present invention is environmentally friendly, has a high reaction yield (the total yield is about 82% or more), a high product purity (the purity of the final product adenosine is above 99.9%), does not require special equipment, and the reagents used are all inexpensive and readily available bulk chemical reagents, and therefore, is suitable for large-scale industrial production. DETAILED DESCRIPTION
[0039] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be described clearly and completely below. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0040] In addition, in order to better illustrate the present invention, numerous specific details are provided in the specific embodiments below. It should be understood by those skilled in the art that the present invention can also be implemented without certain specific details. In some embodiments, raw materials, elements, methods, means, etc. well known to those skilled in the art are not described in detail, so as to highlight the main purpose of the present invention.
[0041] Unless explicitly stated otherwise, throughout the specification and claims, the term "comprise" or variations such as "include" or "comprising" etc., will be understood to include the stated components but not to exclude other components.
[0042] Example 1: Preparation of adenosine according to the method of the present invention:
[0043] As a representative example of the preparation method of the present invention, adenosine is prepared by the following steps in this embodiment:
[0044] 1. The synthesis of compound 3, the reaction flow is as follows:
[0045]
[0046] Compound 1 (5 kg, 32.35 mol) was added to a 50 L reactor, and 20 L of tetrahydrofuran was added. TBD (225 g, 1.62 mol) was added at 20-30 ° C, and stirred for 1 h. Compound 2 (13.39 kg, 42.07 mol) was then added. The reaction system was heated to 55 ° C, stirred for 5 h, cooled to room temperature, 10 L of saturated ammonium chloride solution was added to the reaction system, stirred for 30 min, separated, 10 L of solvent was removed from the organic phase at 40-50 ° C under reduced pressure, 20 L of n-heptane was added to the system, cooled to 0 ° C, stirred for crystallization for 2 h, filtered, and dried under reduced pressure at 20-30 ° C to obtain 12.14 kg of solid product, i.e., compound 3, with a purity of 99.5% and a yield of 90.9%.
[0047] Structure confirmation:
[0048] Hydrogen spectrum solvent CDCl3 2.00~2.20ppm(9H), 4.3~4.5ppm(3H), 5.61ppm(1H), 5.92ppm(1H), 6.12ppm(1H), 8.31-8.73ppm(2H).
[0049] Carbon spectrum solvent CDCl320.66ppm, 20.45ppm, 20.30ppm, 62.86ppm, 70.43ppm, 73.06ppm, 80.50ppm, 86.88ppm, 132.29ppm, 143.73ppm, 151.24ppm, 151.46ppm, 152.22ppm, 162.50ppm, 169.49ppm, 170.17ppm.
[0050] Mass spectrum: [M+H] + :413.32.
[0051] 2. Compound (I) (i.e., adenosine) is prepared from compound 3, and the reaction flow is as follows:
[0052]
[0053] Compound 3 (12 kg, 29.07 mol), triethylamine (3.82 kg, 37.79 mol) and 96 L of 20% ammonia water were added to a 200 L reactor, heated to 55 ° C and stirred for reaction for 10 h, cooled to 10 ° C, filtered to obtain crude adenosine, added to 90 L purified water, added with 300 g of activated carbon, heated to reflux for 2 h, hot filtered, the filtrate was cooled to 20 ° C for crystallization for 4 h, filtered, and dried to obtain 7.11 kg of solid product, namely compound (I) (i.e., adenosine); purity: 99.96%, yield: 91.5%
[0054] Structure confirmation:
[0055] Hydrogen Spectroscopy Solvent DMSO
[0056] 3.50-3.70ppm(2H), 3.90-4.00ppm(1H), 4.10-4.20ppm(1H), 4.60-4.65ppm(1H), 5.20 ppm(1H), 5.42-5.47ppm(2H), 5.89ppm(1H), 7.36ppm(2H), 8.15ppm(1H), 8.36ppm(1H).
[0057] Carbon Spectroscopy Solvent DMSO
[0058] 62.15ppm, 86.37ppm, 71.14ppm, 73.91ppm, 88.39ppm, 119.84ppm, 140.42ppm, 149.53, 152.86ppm, 156.64ppm.
[0059] Mass spectrum: [M+H]+=268.11.
[0060] In the preparation method of this embodiment, the two-step total yield of the final product adenosine is 83.2%.
[0061] Example 2: Preparation of adenosine according to the method of the present invention:
[0062] The difference from Example 1 is that in step 1, the molar ratio of compound 1 to compound 2 is changed from 1:1.3 to 1:1.25, and other conditions remain unchanged; the purity of compound 3 obtained in step 1 is 99.4%, and the yield is 90.2%; the yield of compound (I) prepared in step 2 is 91.2%, and the purity is 99.95%.
[0063] In the preparation method of this embodiment, the two-step total yield of the final product adenosine is 82.3%.
[0064] Example 3: Preparation of adenosine according to the method of the present invention:
[0065] The difference from Example 1 is that in step 1, the base is changed from triethylamine to diethylamine, and other conditions remain unchanged; the purity of compound 3 obtained in step 1 is 99.2%, and the yield is 90.0%; the yield of compound (I) prepared in step 2 is 91.3%, and the purity is 99.94%.
[0066] In the preparation method of this embodiment, the two-step total yield of the final product adenosine is 82.2%.
[0067] Example 4: Preparation of adenosine according to the method of the present invention:
[0068] The difference from Example 1 is that in step 1, the aminating agent is changed from ammonia to ammonium carbonate, and other conditions remain unchanged; the purity of compound 3 obtained in step 1 is 99.1%, and the yield is 89.8%; the yield of compound (I) prepared in step 2 is 91.1%, and the purity is 99.96%.
[0069] In the preparation method of this embodiment, the two-step total yield of the final product adenosine is 81.8%.
[0070] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the present invention.
Claims
1. A method for preparing adenosine, characterized in that: The preparation method comprises the following steps: (a) in the presence of a catalyst, 1,5,7-triazidobicyclo(4.4.0)dec-5-ene, 6-chloropurine and tetraacetylribose are subjected to an amine ester exchange reaction to obtain chlorotriacetylinosine; wherein the molar ratio of 6-chloropurine to tetraacetylribose is 1:(1.2-1.4); (b) in the presence of a base, under normal pressure and heating conditions, subjecting triacetylinosine chloride to an aminating reaction with an aminating agent to obtain adenosine; The reaction formula of the preparation method is as follows:
2. The preparation method according to claim 1, characterized in that: In step (a), the molar ratio of 6-chloropurine to the catalyst 1,5,7-triazidebicyclo(4.4.0)dec-5-ene is 1:(0.01-0.2).
3. The preparation method according to claim 1, characterized in that: In step (a), the molar ratio of 6-chloropurine to the catalyst 1,5,7-triazidebicyclo(4.4.0)dec-5-ene is 1:0.
05.
4. The preparation method according to claim 1, characterized in that: In step (a), the amine transesterification reaction is carried out in a solvent, and the solvent is tetrahydrofuran and / or 1,4-dioxane; And / or, the amine transesterification reaction is carried out at 40-60°C.
5. The preparation method according to claim 1, characterized in that: In step (b), the base is selected from one or more of triethylamine, diethylamine and diisopropylethylamine.
6. The preparation method according to claim 1, characterized in that: In step (b), the molar ratio of triacetylinosine chloride to the base is 1:(1-2).
7. The preparation method according to claim 1, characterized in that: In step (b), the molar ratio of triacetylinosine chloride to base is 1:(1.2-1.4).
8. The preparation method according to claim 1, characterized in that: In step (b), the aminating agent is selected from one or more of ammonia, ammonium chloride, ammonium carbonate and ammonium acetate; And / or, in step (b), the amination reaction is carried out at 40-60°C.
9. The preparation method according to claim 1, characterized in that: In step (b), the amination reagent is selected from: one or more of aqueous ammonia, aqueous ammonium chloride solution, aqueous ammonium carbonate solution and aqueous ammonium acetate solution; and / or, in step (b), the amination reaction is carried out at 40-60°C.
10. Use of the preparation method according to any one of claims 1 to 9 in the preparation of adenosine.
Citation Information
Patent Citations
Method for preparing adenosine
CN100460416C
A method for preparing an adenosine raw material drug
CN111808157B
Process for producing adenosin by chemical synthesis
CN1408720A
Intermediate for synthesizing 2-chloroadenosine, synthesis process of intermediate and synthesis process of 2-chloroadenosine
CN112159447A
